Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) in People with Cystic Fibrosis in the United States
{{output}}
Rationale: Limited data exist on whether the benefits of elexacaftor/tezacaftor/ivacaftor (ETI) seen in randomized controlled trials are sustained in clinical practice in people with cystic fibrosis (PwCF) taking ETI. ... ...
